-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
21 million large purchase orders
Recently, Ganzhou City Public Resource Trading Center released a project bidding information.
The Quannan County Hospital of Integrated Traditional Chinese and Western Medicine in Jiangxi Province purchased a batch of medical equipment, including suspended DR, mammography, color Doppler ultrasound, monitor, defibrillator, anesthesia 82 kinds of medical equipment such as machines and nucleic acid extractors, with a total budget of 21,618,672 yuan, and it is clear that only domestic products are required
.
The Quannan County Hospital of Integrated Traditional Chinese and Western Medicine in Jiangxi Province purchased a batch of medical equipment, including suspended DR, mammography, color Doppler ultrasound, monitor, defibrillator, anesthesia 82 kinds of medical equipment such as machines and nucleic acid extractors, with a total budget of 21,618,672 yuan, and it is clear that only domestic products are required
.
In the end, Sinopharm Holding Jiangxi Medical Device Supply Chain Co.
, Ltd.
won the bid for the project with 21,511,280 yuan.
The winning product brands include GE, Mindray, Shenzhen Libang, Yuyue, Shanchao, Ningbo Dawei, Tianlong, Dongfeng Hongxing, Laoken, etc.
business
.
, Ltd.
won the bid for the project with 21,511,280 yuan.
The winning product brands include GE, Mindray, Shenzhen Libang, Yuyue, Shanchao, Ningbo Dawei, Tianlong, Dongfeng Hongxing, Laoken, etc.
business
.
Prioritize the purchase of domestic equipment
It is worth noting that all the products that won the bid this time are "domestic products"
.
.
Among them, the winning price of a single GE Medical Suspension DR (Definium Tempo) is 2.
587 million.
This product is a new product of GE Medical's 2021 DR series, which also belongs to the "domestic" category
.
587 million.
This product is a new product of GE Medical's 2021 DR series, which also belongs to the "domestic" category
.
It is reported that the Definium Tempo series products are completely designed in China, designed for China, and made in China
.
.
The Senographe Crystal Nova, a digital mammography diagnostic system for GE Healthcare, is not only part of the image post-processing R&D team in Beijing, but GE also places the entire production line in its factory in Beijing
.
.
According to the provisions of China's "Government Procurement Law", government procurement is based on the principle of purchasing domestic goods, projects and services, and the "domestic goods" mentioned here also include foreign brand equipment produced by wholly foreign-owned joint ventures in China.
.
.
For a long time, China's medical device market has been dominated by foreign companies.
With in-depth insights into the Chinese market, giant machinery companies such as Philips, Siemens, Medtronic, Johnson & Johnson, and Abbott have been accelerating the deployment of "localization" strategies in recent years
.
With in-depth insights into the Chinese market, giant machinery companies such as Philips, Siemens, Medtronic, Johnson & Johnson, and Abbott have been accelerating the deployment of "localization" strategies in recent years
.
The layout of giant machinery enterprises is "localized"
Today, multinational machinery companies are no longer limited to selling products as agents in China or building factories and manufacturing, but directly carry out innovation and research and development in China.
Whether they are building innovation platforms or participating in cutting-edge technology projects, they are trying to give the local Chinese Innovation genes, so as to form an innovation ecology, so as to consolidate the company's own market position
.
Whether they are building innovation platforms or participating in cutting-edge technology projects, they are trying to give the local Chinese Innovation genes, so as to form an innovation ecology, so as to consolidate the company's own market position
.
In the past six months, in addition to the latest DR released by GE Healthcare, Siemens' first "domestic" ultrasonic diagnostic equipment has also been officially rolled out in Shanghai!
Mr.
Ma Jinxian, General Manager of the Ultrasound Division of Siemens Healthineers Greater China, once said: In response to the needs of Chinese customers, Siemens Healthineers actively promotes the local production of ultrasound equipment
.
Ma Jinxian, General Manager of the Ultrasound Division of Siemens Healthineers Greater China, once said: In response to the needs of Chinese customers, Siemens Healthineers actively promotes the local production of ultrasound equipment
.
Recently, according to the first financial information, Medtronic Group , the world's largest medical device
company, is considering increasing the production scale of its core cardiovascular devices in China .
It is reported that Medtronic will invest hundreds of millions of RMB in Shanghai Lingang to establish related product lines
.
company, is considering increasing the production scale of its core cardiovascular devices in China .
It is reported that Medtronic will invest hundreds of millions of RMB in Shanghai Lingang to establish related product lines
.
According to information disclosed by Lingang, the initial investment of the Medtronic Lingang project is about 300 million yuan, which will be used for the research and development and industrialization of cardiovascular disease-related products
.
The plant of the project is expected to be delivered in June this year, and will be put into production within 5 years after delivery.
It is expected to reach production in the third year after it is put into production.
The annual output value is expected to be about 300 million yuan after production
.
.
The plant of the project is expected to be delivered in June this year, and will be put into production within 5 years after delivery.
It is expected to reach production in the third year after it is put into production.
The annual output value is expected to be about 300 million yuan after production
.
Gu Yushao, senior vice president of Medtronic and president of Greater China, said in an interview with the first financial reporter: "China's medical market has a huge unmet need.
In the future, China will not only become the world's largest medical device market, but also will certainly Become one of the important sources of innovation for medical devices in the world
.
Medtronic will promote the local R&D and production plan of high-end product lines in China
.
”
In the future, China will not only become the world's largest medical device market, but also will certainly Become one of the important sources of innovation for medical devices in the world
.
Medtronic will promote the local R&D and production plan of high-end product lines in China
.
”
21 million large purchase orders
Recently, Ganzhou City Public Resource Trading Center released a project bidding information.
The Quannan County Hospital of Integrated Traditional Chinese and Western Medicine in Jiangxi Province purchased a batch of medical equipment, including suspended DR, mammography, color Doppler ultrasound, monitor, defibrillator, anesthesia 82 kinds of medical equipment such as machines and nucleic acid extractors, with a total budget of 21,618,672 yuan, and it is clear that only domestic products are required
.
The Quannan County Hospital of Integrated Traditional Chinese and Western Medicine in Jiangxi Province purchased a batch of medical equipment, including suspended DR, mammography, color Doppler ultrasound, monitor, defibrillator, anesthesia 82 kinds of medical equipment such as machines and nucleic acid extractors, with a total budget of 21,618,672 yuan, and it is clear that only domestic products are required
.
In the end, Sinopharm Holding Jiangxi Medical Device Supply Chain Co.
, Ltd.
won the bid for the project with 21,511,280 yuan.
The winning product brands include GE, Mindray, Shenzhen Libang, Yuyue, Shanchao, Ningbo Dawei, Tianlong, Dongfeng Hongxing, Laoken, etc.
business
.
, Ltd.
won the bid for the project with 21,511,280 yuan.
The winning product brands include GE, Mindray, Shenzhen Libang, Yuyue, Shanchao, Ningbo Dawei, Tianlong, Dongfeng Hongxing, Laoken, etc.
business
.
Prioritize the purchase of domestic equipment
It is worth noting that all the products that won the bid this time are "domestic products"
.
.
Among them, the winning price of a single GE Medical Suspension DR (Definium Tempo) is 2.
587 million.
This product is a new product of GE Medical's 2021 DR series, which also belongs to the "domestic" category
.
587 million.
This product is a new product of GE Medical's 2021 DR series, which also belongs to the "domestic" category
.
It is reported that the Definium Tempo series products are completely designed in China, designed for China, and made in China
.
.
The Senographe Crystal Nova, a digital mammography diagnostic system for GE Healthcare, is not only part of the image post-processing R&D team in Beijing, but GE also places the entire production line in its factory in Beijing
.
.
According to the provisions of China's "Government Procurement Law", government procurement is based on the principle of purchasing domestic goods, projects and services, and the "domestic goods" mentioned here also include foreign brand equipment produced by wholly foreign-owned joint ventures in China.
.
.
For a long time, China's medical device market has been dominated by foreign companies.
With in-depth insights into the Chinese market, giant machinery companies such as Philips, Siemens, Medtronic, Johnson & Johnson, and Abbott have been accelerating the deployment of "localization" strategies in recent years
.
With in-depth insights into the Chinese market, giant machinery companies such as Philips, Siemens, Medtronic, Johnson & Johnson, and Abbott have been accelerating the deployment of "localization" strategies in recent years
.
The layout of giant machinery enterprises is "localized"
Today, multinational machinery companies are no longer limited to selling products as agents in China or building factories and manufacturing, but directly carry out innovation and research and development in China.
Whether they are building innovation platforms or participating in cutting-edge technology projects, they are trying to give the local Chinese Innovation genes, so as to form an innovation ecology, so as to consolidate the company's own market position
.
Whether they are building innovation platforms or participating in cutting-edge technology projects, they are trying to give the local Chinese Innovation genes, so as to form an innovation ecology, so as to consolidate the company's own market position
.
In the past six months, in addition to the latest DR released by GE Healthcare, Siemens' first "domestic" ultrasonic diagnostic equipment has also been officially rolled out in Shanghai!
Mr.
Ma Jinxian, General Manager of the Ultrasound Division of Siemens Healthineers Greater China, once said: In response to the needs of Chinese customers, Siemens Healthineers actively promotes the local production of ultrasound equipment
.
Ma Jinxian, General Manager of the Ultrasound Division of Siemens Healthineers Greater China, once said: In response to the needs of Chinese customers, Siemens Healthineers actively promotes the local production of ultrasound equipment
.
Recently, according to the first financial information, Medtronic Group , the world's largest medical device
company, is considering increasing the production scale of its core cardiovascular devices in China .
It is reported that Medtronic will invest hundreds of millions of RMB in Shanghai Lingang to establish related product lines
.
company, is considering increasing the production scale of its core cardiovascular devices in China .
It is reported that Medtronic will invest hundreds of millions of RMB in Shanghai Lingang to establish related product lines
.
According to information disclosed by Lingang, the initial investment of the Medtronic Lingang project is about 300 million yuan, which will be used for the research and development and industrialization of cardiovascular disease-related products
.
The plant of the project is expected to be delivered in June this year, and will be put into production within 5 years after delivery.
It is expected to reach production in the third year after it is put into production.
The annual output value is expected to be about 300 million yuan after production
.
.
The plant of the project is expected to be delivered in June this year, and will be put into production within 5 years after delivery.
It is expected to reach production in the third year after it is put into production.
The annual output value is expected to be about 300 million yuan after production
.
Gu Yushao, senior vice president of Medtronic and president of Greater China, said in an interview with the first financial reporter: "China's medical market has a huge unmet need.
In the future, China will not only become the world's largest medical device market, but also will certainly Become one of the important sources of innovation for medical devices in the world
.
Medtronic will promote the local R&D and production plan of high-end product lines in China
.
”
In the future, China will not only become the world's largest medical device market, but also will certainly Become one of the important sources of innovation for medical devices in the world
.
Medtronic will promote the local R&D and production plan of high-end product lines in China
.
”
21 million large purchase orders
21 million large purchase orders Recently, Ganzhou City Public Resource Trading Center released a project bidding information.
The Quannan County Hospital of Integrated Traditional Chinese and Western Medicine in Jiangxi Province purchased a batch of medical equipment, including suspended DR, mammography, color Doppler ultrasound, monitor, defibrillator, anesthesia 82 kinds of medical equipment such as machines and nucleic acid extractors, with a total budget of 21,618,672 yuan, and it is clear that only domestic products are required
.
Hospital Procurement Hospital Hospital Procurement _The Quannan County Hospital of Integrated Traditional Chinese and Western Medicine in Jiangxi Province purchased a batch of medical equipment, including suspended DR, mammography, color Doppler ultrasound, monitor, defibrillator, anesthesia 82 kinds of medical equipment such as machines and nucleic acid extractors, with a total budget of 21,618,672 yuan, and it is clear that only domestic products are required
.
In the end, Sinopharm Holding Jiangxi Medical Device Supply Chain Co.
, Ltd.
won the bid for the project with 21,511,280 yuan.
The winning product brands include GE, Mindray, Shenzhen Libang, Yuyue, Shanchao, Ningbo Dawei, Tianlong, Dongfeng Hongxing, Laoken, etc.
business
.
enterprise enterprise enterprise, Ltd.
won the bid for the project with 21,511,280 yuan.
The winning product brands include GE, Mindray, Shenzhen Libang, Yuyue, Shanchao, Ningbo Dawei, Tianlong, Dongfeng Hongxing, Laoken, etc.
business
.
Prioritize the purchase of domestic equipment
Prioritize the purchase of domestic equipment It is worth noting that all the products that won the bid this time are "domestic products"
.
.
Among them, the winning price of a single GE Medical Suspension DR (Definium Tempo) is 2.
587 million.
This product is a new product of GE Medical's 2021 DR series, which also belongs to the "domestic" category
.
587 million.
This product is a new product of GE Medical's 2021 DR series, which also belongs to the "domestic" category
.
It is reported that the Definium Tempo series products are completely designed in China, designed for China, and made in China
.
.
The Senographe Crystal Nova, a digital mammography diagnostic system for GE Healthcare, is not only part of the image post-processing R&D team in Beijing, but GE also places the entire production line in its factory in Beijing
.
.
According to the provisions of China's "Government Procurement Law", government procurement is based on the principle of purchasing domestic goods, projects and services, and the "domestic goods" mentioned here also include foreign brand equipment produced by wholly foreign-owned joint ventures in China.
.
.
For a long time, China's medical device market has been dominated by foreign companies.
With in-depth insights into the Chinese market, giant machinery companies such as Philips, Siemens, Medtronic, Johnson & Johnson, and Abbott have been accelerating the deployment of "localization" strategies in recent years
.
With in-depth insights into the Chinese market, giant machinery companies such as Philips, Siemens, Medtronic, Johnson & Johnson, and Abbott have been accelerating the deployment of "localization" strategies in recent years
.
The layout of giant machinery enterprises is "localized"
The layout of giant machinery enterprises is "localized" Today, multinational machinery companies are no longer limited to selling products as agents in China or building factories and manufacturing, but directly carry out innovation and research and development in China.
Whether they are building innovation platforms or participating in cutting-edge technology projects, they are trying to give the local Chinese Innovation genes, so as to form an innovation ecology, so as to consolidate the company's own market position
.
agent agent agentWhether they are building innovation platforms or participating in cutting-edge technology projects, they are trying to give the local Chinese Innovation genes, so as to form an innovation ecology, so as to consolidate the company's own market position
.
In the past six months, in addition to the latest DR released by GE Healthcare, Siemens' first "domestic" ultrasonic diagnostic equipment has also been officially rolled out in Shanghai!
Mr.
Ma Jinxian, General Manager of the Ultrasound Division of Siemens Healthineers Greater China, once said: In response to the needs of Chinese customers, Siemens Healthineers actively promotes the local production of ultrasound equipment
.
Ma Jinxian, General Manager of the Ultrasound Division of Siemens Healthineers Greater China, once said: In response to the needs of Chinese customers, Siemens Healthineers actively promotes the local production of ultrasound equipment
.
Recently, according to the first financial information, Medtronic Group , the world's largest medical device
company, is considering increasing the production scale of its core cardiovascular devices in China .
It is reported that Medtronic will invest hundreds of millions of RMB in Shanghai Lingang to establish related product lines
.
medical device medical device medical devicecompany, is considering increasing the production scale of its core cardiovascular devices in China .
It is reported that Medtronic will invest hundreds of millions of RMB in Shanghai Lingang to establish related product lines
.
According to information disclosed by Lingang, the initial investment of the Medtronic Lingang project is about 300 million yuan, which will be used for the research and development and industrialization of cardiovascular disease-related products
.
The plant of the project is expected to be delivered in June this year, and will be put into production within 5 years after delivery.
It is expected to reach production in the third year after it is put into production.
The annual output value is expected to be about 300 million yuan after production
.
.
The plant of the project is expected to be delivered in June this year, and will be put into production within 5 years after delivery.
It is expected to reach production in the third year after it is put into production.
The annual output value is expected to be about 300 million yuan after production
.
Gu Yushao, senior vice president of Medtronic and president of Greater China, said in an interview with the first financial reporter: "China's medical market has a huge unmet need.
In the future, China will not only become the world's largest medical device market, but also will certainly Become one of the important sources of innovation for medical devices in the world
.
Medtronic will promote the local R&D and production plan of high-end product lines in China
.
”
In the future, China will not only become the world's largest medical device market, but also will certainly Become one of the important sources of innovation for medical devices in the world
.
Medtronic will promote the local R&D and production plan of high-end product lines in China
.
”
